Latest News

  • RESEARCH

    27 Feb 2026

    Can AI Crack the Code on Fibrosis?

  • INNOVATION

    25 Feb 2026

    AI Unlocks the Secret to Cell Entry

  • PARTNERSHIPS

    24 Feb 2026

    U.S. Peptide Groups Form GMP Alliance

  • INVESTMENT

    23 Feb 2026

    $305mn Bet on Peptides Signals Shift in Cancer

AI-Designed Peptide Enters Late-Stage Infection Trial

White pills and capsule with thermometer on dollar notes

INNOVATION

20 Feb 2026

Peptilogics advances zaloganan into Phase 2/3 with $120mn in funding to tackle biofilm-related joint infections 

Pre-filled GLP-1 injection pens used in obesity and metabolic disease treatment

REGULATORY

15 Jan 2026

FDA Reasserts Limits as GLP-1 Shortages Fade

As GLP-1 drug shortages ease, the FDA is enforcing long-standing compounding limits, reshaping risk and forcing peptide firms to adapt

Gloved hands holding blue and white capsules

PARTNERSHIPS

13 Jan 2026

Merck and PeptiDream Explore a New Angle on COVID-19

A PeptiDream and Merck partnership spotlights peptides as a flexible, early-stage antiviral option for COVID-19 and beyond

Eli Lilly signage on a pharmaceutical company building with a US flag above

INNOVATION

9 Jan 2026

The Race to Replace Needles With Pills Gets Smarter

AI-powered collaborations are speeding oral obesity and diabetes drugs, promising easier dosing and a faster path from discovery to market

Gloved hands loading test tubes into automated lab equipment.

PARTNERSHIPS

16 Dec 2025

Peptide Drugs Hit Fast-Forward With AI at the Bench

Announced July 30, 2025, a US partnership uses AI platforms and lab testing to cut peptide drug timelines and push earlier data-driven dis...

Researcher using pipette during laboratory testing for peptide drug development

INNOVATION

12 Dec 2025

Can Next-Gen Peptides Redefine Weight Loss Medicine?

Next gen peptides show about 28.7 percent weight loss and raise the bar for future obesity drugs

Scientist using a tablet for peptide research in a modern lab with microscope nearby

TECHNOLOGY

10 Dec 2025

Peptide Design Gets a Power Boost From AI

Nabla Bio and Takeda push AI driven peptide design forward, reshaping how fast new therapies emerge

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.